Parabilis Medicines, Inc.
United States, Cambridge, MA
About Parabilis Medicines, Inc.
Parabilis Medicines is a clinical-stage biopharmaceutical company developing Helicon peptide-based therapies to drug historically undruggable intracellular targets, with a lead program focused on cancer treatment.
Latest Funding
Series C+Announced 2026-01-08
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
2 signals · where the capital is going
Advancing pioneering discovery pipeline and expanding Helicon peptide platform for intracellular oncology targets
biospace.com
+1 more capital deployment signal · confidence ratings · source articles
Sign up freeHiring Signals
18 open roles · capital meeting headcount
R&D spend backed by 4 engineering hires, product build in motion
Roles in United States and Cambridge and 1 more
+2 more hiring signals · full department matrix · role-by-role drill-down
Sign up freeTop hiring departments
In the news
Selling to Parabilis Medicines, Inc.? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Parabilis Medicines, Inc..
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Parabilis Medicines, Inc., and who are their main competitors?
Sign up free to ask AI about Parabilis Medicines, Inc.
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
General Catalyst
Lead investor · Series C+
Tech Stack
Font Awesome
HTTP/3
Yoast SEO
Key Highlights
AI InsightsFunding will also advance Parabilis’ discovery-stage pipeline, including prostate cancer programs, and further development of its Helicon platform for historically undruggable targets.[3][4][6][8]
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Parabilis Medicines, Inc.
Selling to Parabilis Medicines, Inc.? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Parabilis Medicines, Inc..
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.